MSH Capital Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Hold
23,682
0.07% 235
2026
Q1
$320K Buy
23,682
+176
+0.7% +$2.46K 0.07% 219
2025
Q4
$293K Buy
23,506
+32
+0.1% +$345 0.06% 224
2025
Q3
$232K Hold
23,474
0.06% 228
2025
Q2
$210K Sell
23,474
-31
-0.1% -$262 0.06% 230
2025
Q1
$205K Hold
23,505
0.06% 225
2024
Q4
$293K Sell
23,505
-3,434
-13% -$42.2K 0.09% 189
2024
Q3
$313K Hold
26,939
0.1% 188
2024
Q2
$286K Buy
26,939
+895
+3% +$9.89K 0.1% 190
2024
Q1
$311K Sell
26,044
-1,592
-6% -$19.2K 0.11% 173
2023
Q4
$299K Sell
27,636
-62,830
-69% -$602K 0.11% 165
2023
Q3
$892K Buy
90,466
+524
+0.6% +$5.46K 0.35% 85
2023
Q2
$898K Buy
89,942
+1,944
+2% +$18.6K 0.33% 86
2023
Q1
$847K Buy
87,998
+6,646
+8% +$73.7K 0.36% 84
2022
Q4
$905K Buy
81,352
+2,172
+3% +$22.7K 0.41% 78
2022
Q3
$675K Buy
79,180
+443
+0.6% +$4.36K 0.33% 90
2022
Q2
$824K Buy
78,737
+2,029
+3% +$22.2K 0.38% 84
2022
Q1
$835K Buy
76,708
+2,432
+3% +$32K 0.34% 88
2021
Q4
$1M Buy
+74,276
New +$992K 0.45% 73

Other funds holding VTRS

MSH Capital Advisors's VTRS Position: Q2 2026 in Review

MSH Capital Advisors held its Viatris (VTRS) position steady in Q2 2026 at 23,682 shares worth $376K. The position accounts for 0.07% of the portfolio, ranked #235.

MSH Capital Advisors first reported a position in VTRS in Q4 2021 and has held it in 19 quarters since. The position peaked at $1M in Q4 2021. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • MSH Capital Advisors held 23,682 shares of Viatris worth $376K as of Q2 2026.
  • MSH Capital Advisors left its Viatris share count unchanged in Q2 2026.
  • Viatris made up 0.07% of MSH Capital Advisors's portfolio in Q2 2026, its #235 holding.
  • MSH Capital Advisors first reported a position in Viatris in Q4 2021 and has held it in 19 quarters since.
  • MSH Capital Advisors's Viatris position peaked at $1M in Q4 2021.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.